Woodline Partners LP Argenx Se Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Argenx Se stock. As of the latest transaction made, Woodline Partners LP holds 89,796 shares of ARGX stock, worth $57.3 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
89,796
Previous 74,237
20.96%
Holding current value
$57.3 Million
Previous $45.7 Million
16.41%
% of portfolio
0.37%
Previous 0.34%
Shares
12 transactions
Others Institutions Holding ARGX
# of Institutions
498Shares Held
28.6MCall Options Held
331KPut Options Held
226K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.43 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.78 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.37 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.24 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$787 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...